Fluorodeoxyglucose positron emission tomography in cutaneous squamous cell carcinoma: Retrospective analysis of 12 patients

Dermatologic Surgery

Volumn 31, Issue 4, 2005, Pages 442-447

  Cho, Sung Bin ^a   Chung, Woo Gil ^a   Yun, Mijin ^a   Lee, Jong Doo ^a   Lee, Min Geol ^a   Chung, Kee Yang ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; FEMALE; HIGH RISK PATIENT; HUMAN; LYMPHOMA; MALE; MELANOMA; NON INVASIVE MEASUREMENT; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; WHOLE BODY SCINTISCANNING;

EID: 16844381920     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042728-200504000-00011     Document Type: Article

References (16)

1. Nabi HA, Zubeldia JM. Clinical applications of (18)F-FDG in oncology. J Nucl Med Technol 2002;30:3-9.
2. Rasanen JV, Sihvo EI, Knuuti MJ, et al. Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction. Ann Surg Oncol 2003;10:954-60.
3. Jadvar H, Pinski JK, Conti PS. FDG PET in suspected recurrent and metastatic prostate cancer. Oncol Rep 2003;10:1485-8.
4. Mijnhout GS, Hoekstra OS, van Tulder MW, et al. Systematic review of the diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography in melanoma patients. Cancer 2001;91:1530-42.
5. Mac Manus MP, Hicks RJ, Ball DL, et al. F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment. Cancer 2001;92:886-95.
6. Weisberg NK, Bertagnolli MM, Becker DS. Combined sentinel lymphadenectomy and Mohs micrographic surgery for high-risk cutaneous squamous cell carcinoma. J Am Acad Dermatol 2000;43:483-8.
7. Warburg O. The metabolism of tumors. New York: Richard R. Smith; 1931.
8. Pauwels EK, Sturm EJ, Bombardieri E, et al. Positron-emission tomography with [18F]fluorodeoxyglucose. Part I. Biochemical uptake mechanism and its implication for clinical studies. J Cancer Res Clin Oncol 2000;126:549-59.
9. Boni R, Boni RA, Steinen H, et al. Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D- glucose. Br J Dermatol 1995;132:556-62.
10. Paul R. Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for the detection of lymphoma. J Nucl Med 1987;28:288-92.
11. Jung J, Cho SB, Yun M, et al. Metastatic malignant proliferating trichilemmal tumor detected by positron emission tomography. Dermatol Surg 2003;29:872-4.
12. Fosko SW, Hu W, Cook TF, Lowe VJ. Positron emission tomography for basal cell carcinoma of the head and neck. Arch Dermatol 2003;139:1141-6.
13. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992;26:976-90.
14. Novick M, Gard DA, Hardy SB, Spira M. Burn scar carcinoma: a review and analysis of 46 cases. J Trauma 1977;17:809-17.
15. Sabin SR, Goldstein G, Rosenthal HG, Haynes KK. Aggressive squamous cell carcinoma originating as a Marjolin's ulcer. Dermatol Surg 2004;30:229-30.
16. Acland KM, Healy C, Calonje E, et al. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma. J Clin Oncol 2001;19:2674-8.